Anti-NG2 antibody
5
(3 Reviews)
|
(29 Publications)
Rabbit Polyclonal NG2 antibody. Suitable for WB, IHC-FoFr and reacts with Human, Rat samples. Cited in 29 publications.
View Alternative Names
MCSP, CSPG4, Chondroitin sulfate proteoglycan 4, Chondroitin sulfate proteoglycan NG2, Melanoma chondroitin sulfate proteoglycan, Melanoma-associated chondroitin sulfate proteoglycan
- IHC-FoFr
Collaborator
Immunohistochemistry (PFA perfusion fixed frozen sections) - Anti-NG2 antibody (AB83178)
IHC-FoFr image of NG2 staining on sections of rat cortex post injury using ab83178 (1 : 100). The brain was perfusion fixed using 4% PFA and the sections were permeabilized using 0.1% TritonX in 0.1% PBS. The sections were then blocked using 10% donkey serum for 1hour at 24°C. ab83178 was diluted 1 : 100 and incubated with the sections for 24 hours at 4°C. The secondary antibody used was donkey polyclonal to rabbit IgG conjugated to Alexa Fluor 488 (1 : 1000).
This image is courtesy of an abreview submitted by Ruma Raha-Chowdhury, University Of Cambridge, United Kingdom
- WB
Unknown
Western blot - Anti-NG2 antibody (AB83178)
Human Chondroitin sulfate proteoglycan 4 precursor (NG2) contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.
All lanes:
Western blot - Anti-NG2 antibody (ab83178) at 1 µg/mL
All lanes:
Human skin tissue lysate - total protein (<a href='/en-us/products/unavailable/human-skin-tissue-lysate-total-protein-ab30166'>ab30166</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 251 kDa
Observed band size: 190 kDa,300 kDa
true
Exposure time: 3min
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (29)
Recent publications for all applications. Explore the full list and refine your search
Journal for immunotherapy of cancer 13: PubMed40425233
2025
Applications
Unspecified application
Species
Unspecified reactive species
Pharmaceutics 16: PubMed39458643
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neuropsychiatric disease and treatment 19:1935-1947 PubMed37719062
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 42:113050 PubMed37597183
2023
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 4:102292 PubMed37149860
2023
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 19:e1011272 PubMed36972308
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neural regeneration research 18:1976-1982 PubMed36926722
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular neurobiology 43:2337-2358 PubMed36547781
2022
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:104813 PubMed35982785
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cellular neuroscience 15:773709 PubMed35095421
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com